Pralatrexate (Folotyn)

pralatrexate · Spectrum Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pralatrexate (Folotyn), covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL [Phase 1]